Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Vsee Health (VSEE) Receivables - Other (2024 - 2025)

Vsee Health filings provide 2 years of Receivables - Other readings, the most recent being $304614.0 for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 42.7% to $304614.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $304614.0, a 42.7% decrease, with the full-year FY2025 number at $304614.0, down 42.7% from a year prior.
  • Receivables - Other hit $304614.0 in Q4 2025 for Vsee Health, up from $284614.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $560380.0 in Q3 2024 to a low of $241122.0 in Q2 2025.